Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Clinical and organisational aspects of haemophilia care: the patients' view.

Literature DB >> 22044947

Clinical and organisational aspects of haemophilia care: the patients' view.

Gabriele Calizzani, Romano Arcieri.

Abstract

Entities: Disease Species

Mesh：

Substances：
Factor VIII

Year: 2011 PMID： 22044947 PMCID： PMC3259000 DOI： 10.2450/2011.0043-11

Source DB: PubMed Journal: Blood Transfus ISSN： 1723-2007 Impact factor: 3.443

× No keyword cloud information.

5 in total

1. Plasma-derived versus recombinant factor VIII concentrates for the treatment of haemophilia A: plasma-derived is better.

Authors: Pier Mannuccio Mannucci
Journal: Blood Transfus Date: 2010-10 Impact factor: 3.443

2. Plasma-derived versus recombinant Factor VIII concentrates for the treatment of haemophilia A: recombinant is better.

Authors: Massimo Franchini
Journal: Blood Transfus Date: 2010-10 Impact factor: 3.443

Review 3. Factor VIII safety: plasma-derived versus recombinant products.

Authors: Alessandro Gringeri
Journal: Blood Transfus Date: 2011-04-12 Impact factor: 3.443

4. Mortality and causes of death in Italian persons with haemophilia, 1990-2007.

Authors: A Tagliaferri; G F Rivolta; A Iorio; E Oliovecchio; M E Mancuso; M Morfini; A Rocino; M G Mazzucconi; M Franchini; N Ciavarella; A Scaraggi; L Valdrè; G Tagariello; P Radossi; G Muleo; P G Iannaccaro; C Biasoli; D Vincenzi; M L Serino; S Linari; C Molinari; E Boeri; M La Pecorella; M T Carloni; E Santagostino; G Di Minno; A Coppola; A Rocino; E Zanon; L Spiezia; C Di Perna; M Marchesini; M Marcucci; A Dragani; S Macchi; P Albertini; M D'Incà; C Santoro; F Biondo; G Piseddu; G Rossetti; G Barillari; G Gandini; A C Giuffrida; G Castaman
Journal: Haemophilia Date: 2010-02-09 Impact factor: 4.287

5. European principles of haemophilia care.

Authors: B T Colvin; J Astermark; K Fischer; A Gringeri; R Lassila; W Schramm; A Thomas; J Ingerslev
Journal: Haemophilia Date: 2008-01-30 Impact factor: 4.287

5 in total

6 in total

1. Factor VIII inhibitor and source of replacement therapy.

Authors: Pier Mannuccio Mannucci; Alessandro Gringeri; Elena Santagostino; Flora Peyvandi
Journal: Blood Transfus Date: 2011-09-21 Impact factor: 3.443

Review 2. Plasma and plasma-derived medicinal product self-sufficiency: the Italian case.

Authors: Gabriele Calizzani; Samantha Profili; Fabio Candura; Monica Lanzoni; Stefania Vaglio; Livia Cannata; Liviana Catalano; Rosa Chianese; Giancarlo M Liumbruno; Giuliano Grazzini
Journal: Blood Transfus Date: 2013-09 Impact factor: 3.443

Review 3. Present and future challenges in the treatment of haemophilia: the patient's perspective.

Authors: Romano Arcieri; Angelo C Molinari; Stefania Farace; Giuseppe Mazza; Alberto Garnero; Gabriele Calizzani; Paola Giordano; Emily Oliovecchio; Lorenzo Mantovani; Lamberto Manzoli; Paul Giangrande
Journal: Blood Transfus Date: 2013-09 Impact factor: 3.443

Review 4. The demand for factor VIII and for factor IX and the toll fractionation product surplus management.

Authors: Gabriele Calizzani; Samantha Profili; Fabio Candura; Monica Lanzoni; Stefania Vaglio; Livia Cannata; Giancarlo M Liumbruno; Massimo Franchini; Pier Mannuccio Mannucci; Giuliano Grazzini
Journal: Blood Transfus Date: 2013-09 Impact factor: 3.443

5. Principles of treatment and update of recommendations for the management of haemophilia and congenital bleeding disorders in Italy.

Authors: Angiola Rocino; Antonio Coppola; Massimo Franchini; Giancarlo Castaman; Cristina Santoro; Ezio Zanon; Elena Santagostino; Massimo Morfini
Journal: Blood Transfus Date: 2014-10 Impact factor: 3.443

Review 6. Uncovered needs in the management of inherited bleeding disorders in Italy.

6 in total